Spin-off - Organon & Co.

Form Type: SD

Filing Date: 2025-06-02

Corporate Action: Spin-off

Type: New

Accession Number: 000110465925055516

Filing Summary: Organon & Co. is a global health care company formed through a spinoff from Merck & Co., Inc. to focus on women's health. The company develops and delivers innovative health solutions through a portfolio of prescription therapies within women's health and operates six manufacturing facilities worldwide. The report details Organon's Conflict Minerals Disclosure, which includes a review of products for the presence and origin of certain conflict minerals. Organon has filed its Conflict Minerals Report as an exhibit to this Form SD, compliant with Rule 13p-1 under the Securities Exchange Act for the reporting period from January 1 to December 31, 2024.